Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A Steady Year For The Top Tier In Pharma Ahead Of Major Upheaval

12 Dec 2019

• By Jessica Merrill

Change on the horizon for big pharma • Source: Shutterstock

Related Content

Opioid Litigation Clouds Loom Over Teva's Turnaround

07 Aug 2019

AbbVie Pounces On Chance To Buy Revenues In $63bn Mega-Deal For Allergan

25 Jun 2019

Bristol Values Celgene's Hematology, Immunology Portfolio At $74bn, But Does It Price In Risk?

04 Jan 2019

Related Companies

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Pfizer Inc.

Novartis AG

Roche Holding AG

Johnson & Johnson

Merck & Co., Inc.

Sanofi

AbbVie Inc.

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Amgen, Inc.

Gilead Sciences, Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

Financing Market Intelligence BioPharmaceutical Outlook 2020

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.